{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:08:47Z","timestamp":1773234527187,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13256-016-1091-4","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T16:28:45Z","timestamp":1477931325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mefloquine-associated dizziness, diplopia, and central serous chorioretinopathy: a case report"],"prefix":"10.1186","volume":"10","author":[{"given":"Manish","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remington L.","family":"Nevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iajaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijpddr.2014.03.002","volume":"4","author":"RL Nevin","year":"2014","unstructured":"Nevin RL. Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine. Int J Parasitol Drugs Drug Resist. 2014;4:118\u201325.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tmaid.2014.10.021","volume":"13","author":"\u00c5 Ringqvist","year":"2015","unstructured":"Ringqvist \u00c5, Bech P, Glenth\u00f8j B, Petersen E. Acute and long-term psychiatric side effects of mefloquine: A follow-up on Danish adverse event reports. Travel Med Infect Dis. 2015;13:80\u20138.","journal-title":"Travel Med Infect Dis"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tmaid.2013.07.007","volume":"12","author":"C Schneider","year":"2013","unstructured":"Schneider C, Adamcova M, Jick SS, Schlagenhauf P, Miller MK, Rhein HG, Meier CR. Use of anti-malarial drugs and the risk of developing eye disorders. Travel Med Infect Dis. 2013;12:40\u20137.","journal-title":"Travel Med Infect Dis"},{"key":"1091_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tmaid.2015.04.005","volume":"13","author":"M Adamcova","year":"2015","unstructured":"Adamcova M, Schaerer MT, Bercaru I, Cockburn I, Rhein HG, Schlagenhauf P. Eye disorders reported with the use of mefloquine (Lariam\u00ae) chemoprophylaxis \u2013 A drug safety database analysis. Travel Med Infect Dis. 2015;13:400\u20138.","journal-title":"Travel Med Infect Dis"},{"key":"1091_CR5","first-page":"224","volume":"41","author":"EC Ritchie","year":"2013","unstructured":"Ritchie EC, Block J, Nevin RL. Psychiatric side effects of mefloquine: applications to forensic psychiatry. J Am Acad Psychiatry Law. 2013;41:224\u201335.","journal-title":"J Am Acad Psychiatry Law"},{"key":"1091_CR6","first-page":"167","volume":"95","author":"JL Bem","year":"1992","unstructured":"Bem JL, Kerr L, Stuerchler D. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg. 1992;95:167\u201379.","journal-title":"J Trop Med Hyg"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3129\/i06-093","volume":"42","author":"RA Walker","year":"2007","unstructured":"Walker RA, Colleaux KM. Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis. Can J Ophthalmol. 2007;42:125\u20136.","journal-title":"Can J Ophthalmol"},{"key":"1091_CR8","doi-asserted-by":"publisher","first-page":"12364","DOI":"10.1073\/pnas.0402044101","volume":"101","author":"SJ Cruikshank","year":"2004","unstructured":"Cruikshank SJ, Hopperstad M, Younger M, Connors BW, Spray DC, Srinivas M. Potent block of Cx36 and Cx50 gap junction channels by mefloquine. Proc Natl Acad Sci U S A. 2004;101:12364\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1167\/iovs.09-4847","volume":"51","author":"NM Kerr","year":"2010","unstructured":"Kerr NM, Johnson CS, de Souza CF, Chee KS, Good WR, Green CR, Danesh-Meyer HV. Immunolocalization of gap junction protein connexin43 (GJA1) in the human retina and optic nerve. Invest Ophthalmol Vis Sci. 2010;51:4028\u201334.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1091_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.exer.2008.01.021","volume":"87","author":"HV Danesh-Meyer","year":"2008","unstructured":"Danesh-Meyer HV, Green CR. Focus on molecules: connexin 43 \u2013 mind the gap. Exp Eye Res. 2008;87:494\u20135.","journal-title":"Exp Eye Res"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archophthalmol.2011.113","volume":"129","author":"LA Gabriel","year":"2011","unstructured":"Gabriel LA, Sachdeva R, Marcotty A, Rockwood EJ, Traboulsi EI. Oculodentodigital dysplasia: new ocular findings and a novel connexin 43 mutation. Arch Ophthalmol. 2011;129:781\u20134.","journal-title":"Arch Ophthalmol"},{"key":"1091_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000360014","volume":"232","author":"R Liegl","year":"2014","unstructured":"Liegl R, Ulbig MW. Central serous chorioretinopathy. Ophthalmologica. 2014;232:65\u201376.","journal-title":"Ophthalmologica"},{"key":"1091_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00133176","volume":"19","author":"C Pr\u00fcnte","year":"1995","unstructured":"Pr\u00fcnte C. Indocyanine green angiographic findings in central serous chorioretinopathy. Int Ophthalmol. 1995;19:77\u201382.","journal-title":"Int Ophthalmol"},{"key":"1091_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/ICB.0b013e31818ad3ce","volume":"3","author":"KK Pierce","year":"2009","unstructured":"Pierce KK, Lane RG. Central serous chorioretinopathy associated with the use of ephedra. Retin Cases Brief Rep. 2009;3:376\u20138.","journal-title":"Retin Cases Brief Rep"},{"key":"1091_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0002-9394(03)00076-X","volume":"136","author":"JC Michael","year":"2003","unstructured":"Michael JC, Pak J, Pulido J, de Venecia G. Central serous chorioretinopathy associated with administration of sympathomimetic agents. Am J Ophthalmol. 2003;136:182\u20135.","journal-title":"Am J Ophthalmol"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/cne.22580","volume":"519","author":"T Kozicz","year":"2011","unstructured":"Kozicz T, Bittencourt JC, May PJ, Reiner A, Gamlin PD, Palkovits M, Horn AK, Toledo CA, Ryabinin AE. The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J Comp Neurol. 2011;519:1413\u201334.","journal-title":"J Comp Neurol"},{"key":"1091_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cne.903060307","volume":"306","author":"P Gamlin","year":"1991","unstructured":"Gamlin P, Reiner A. The Edinger-Westphal nucleus: sources of input influencing accommodation, pupilloconstriction, and choroidal blood flow. J Comp Neurol. 1991;306:425\u201338.","journal-title":"J Comp Neurol"},{"key":"1091_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S0952523898152070","volume":"15","author":"W Hodos","year":"1998","unstructured":"Hodos W, Miller RF, Ghim MM, Fitzgerald ME, Toledo C, Reiner A. Visual acuity losses in pigeons with lesions of the nucleus of Edinger-Westphal that disrupt the adaptive regulation of choroidal blood flow. Vis Neurosci. 1998;15:273\u201387.","journal-title":"Vis Neurosci"},{"key":"1091_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainres.2007.04.053","volume":"1156","author":"MB Lassen","year":"2007","unstructured":"Lassen MB, Brown JE, Stobbs SH, Gunderson SH, Maes L, Valenzuela CF, Ray AP, Henriksen SJ, Steffensen SC. Brain stimulation reward is integrated by a network of electrically coupled GABA neurons. Brain Res. 2007;1156:46\u201358.","journal-title":"Brain Res"},{"key":"1091_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00005072-195107000-00001","volume":"10","author":"IG Schmidt","year":"1951","unstructured":"Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. III. The effects of pentaquine, isopentaquine, primaquine, and pamaquine on the central nervous system of the rhesus monkey. J Neuropathol Exp Neurol. 1951;10:231\u201356.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1091_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00005072-194810000-00002","volume":"7","author":"IG Schmidt","year":"1948","unstructured":"Schmidt IG, Schmidt LH. Neurotoxicity of the 8-aminoquinolines. I. Lesions in the Central Nervous System of the Rhesus Monkey Induced by Administration of Plasmocid. J Neuropathol Exp Neurol. 1948;7:368\u201398.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1091_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4269\/ajtmh.1949.s1-29.341","volume":"29","author":"AC Loken","year":"1949","unstructured":"Loken AC, Haymaker W. Pamaquine poisoning in man, with a clinicopathologic study of one case. Am J Trop Med Hyg. 1949;29:341\u201352.","journal-title":"Am J Trop Med Hyg"},{"key":"1091_CR23","first-page":"563","volume":"79","author":"P Rheeder","year":"1991","unstructured":"Rheeder P, Sieling WL. Acute, persistent quinine-induced blindness. A case report. South African Med J. 1991;79:563\u20134.","journal-title":"South African Med J"},{"key":"1091_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/bjo.72.1.23","volume":"72","author":"CR Canning","year":"1988","unstructured":"Canning CR, Hague S. Ocular quinine toxicity. Br J Ophthalmol. 1988;72:23\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1091_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bjo.72.3.219","volume":"72","author":"P Bacon","year":"1988","unstructured":"Bacon P, Spalton DJ, Smith SE. Blindness from quinine toxicity. Br J Ophthalmol. 1988;72:219\u201324.","journal-title":"Br J Ophthalmol"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/bjo.15.3.164","volume":"15","author":"J Duggan","year":"1931","unstructured":"Duggan J, Nanavati B. A case of quinine amblyopia with a central colour scotoma of one eye and total blindness of the other. Br J Ophthalmol. 1931;15:164\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1091_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tmaid.2012.03.006","volume":"10","author":"RL Nevin","year":"2012","unstructured":"Nevin RL. Limbic encephalopathy and central vestibulopathy caused by mefloquine: A case report. Travel Med Infect Dis. 2012;10:144\u201351.","journal-title":"Travel Med Infect Dis"},{"key":"1091_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1128\/AAC.50.3.1045-1053.2006","volume":"50","author":"G Dow","year":"2006","unstructured":"Dow G, Bauman R, Caridha D, Cabezas M, Du F, Gomez-Lobo R, Park M, Smith K, Cannard K. Mefloquine induces dose-related neurological effects in a rat model. Antimicrob Agents Chemother. 2006;50:1045\u201353.","journal-title":"Antimicrob Agents Chemother"},{"key":"1091_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/jac\/dki414","volume":"57","author":"E Fiaccadori","year":"2006","unstructured":"Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Cabassi A, Ariya K, Wirote L. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine. J Antimicrob Chemother. 2006;57:160\u20131.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"1091_CR30","first-page":"63","volume":"62","author":"LA Salako","year":"1984","unstructured":"Salako LA. Toxicity and side-effects of antimalarials in Africa: a critical review. Bull World Health Organ. 1984;62(Suppl):63\u20138.","journal-title":"Bull World Health Organ"},{"key":"1091_CR31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/AAC.14.5.680","volume":"14","author":"LH Schmidt","year":"1978","unstructured":"Schmidt LH, Crosby R, Rasco J, Vaughan D. Antimalarial activities of the 4-quinolinemethanols WR-184,806 and WR-226,253. Antimicrob Agents Chemother. 1978;14:680\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"1091_CR32","first-page":"221","volume-title":"A Survey of Antimalarial Drugs, 1941\u20131945","author":"R Berliner","year":"1946","unstructured":"Berliner R, Butler T. Summary of Data on the Drugs Tested in Man. In: Wiselogle FY, editor. A Survey of Antimalarial Drugs, 1941\u20131945, vol. 1. Ann Arbor: J.W. Edwards; 1946. p. 221\u2013451."},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1172\/JCI101980","volume":"27","author":"RW Berliner","year":"1948","unstructured":"Berliner RW, Earle DP, Taggart JV, Zubrod CG, Welch WJ, Conan NJ, Bauman E, Scudder ST, Shannon JA. Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline. J Clin Invest. 1948;27:98\u2013107.","journal-title":"J Clin Invest"},{"key":"1091_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejps.2006.05.009","volume":"29","author":"R Hayeshi","year":"2006","unstructured":"Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell A-LB. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur J Pharm Sci. 2006;29:70\u201381.","journal-title":"Eur J Pharm Sci"},{"key":"1091_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/bdd.343","volume":"24","author":"K Tsujikawa","year":"2003","unstructured":"Tsujikawa K, Dan Y, Nogawa K, Sato H, Yamada Y, Murakami H, Ohtani H, Sawada Y, Iga T. Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A. Biopharm Drug Dispos. 2003;24:105\u201314.","journal-title":"Biopharm Drug Dispos"},{"key":"1091_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bpc.2006.07.006","volume":"125","author":"SA Lima","year":"2007","unstructured":"Lima SA, Cordeiro-da-Silva A, de Castro B, Gameiro P. Sensitivity of P-glycoprotein tryptophan residues to benzodiazepines and ATP interaction. Biophys Chem. 2007;125:143\u201350.","journal-title":"Biophys Chem"},{"key":"1091_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00210-001-0489-7","volume":"364","author":"C Pauli-Magnus","year":"2014","unstructured":"Pauli-Magnus C, Rekersbrink S, Klotz U, Fromm MF. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. Naunyn Schmiedebergs Arch Pharmacol. 2014;364:551\u20137.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-016-1091-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-016-1091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:27:33Z","timestamp":1498357653000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-016-1091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s13256-016-1091-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]},"article-number":"305"}}